Optimizing chronic kidney disease management: The potential of a multi-strain probiotic formulation.

2025-03-25
World journal of nephrology 14(1)
- Deodatta Chafekar

PubMed: 40134645
DOI: 10.5527/wjn.v14.i1.101515

Study Design

Type: Review

Chronic kidney disease (CKD), which represents a significant global health concern, is characterized by a gradual decline in kidney function, leading to complications such as electrolyte imbalance, cardiovascular disease, and immune dysfunction. Standard CKD management includes dietary modifications, ketoanalogues supplementation, blood pressure and blood glucose control, hydration maintenance, and treatment of the underlying causes. Emerging evidence has indicated a significant role of the gut microbiota in CKD, and that dysbiosis of the gut microbiota contributes to the progression of CKD towards end-stage renal disease. Probiotics and prebiotics have recently garnered attention owing to their potential to enhance gastrointestinal health and well-being by restoring the balance of the gut microbiota. Specific probiotic strains, including Lactobacillus and Bifidobacterium, promote beneficial bacterial growth, suppress harmful bacteria, and exert anti-inflammatory, antihypertensive, and antidiabetic effects. The combination of Streptococcus thermophilus, Lactobacillus acidophilus, Bifidobacterium longum, and Bacillus coagulans has demonstrated potential as a therapeutic formulation for CKD management in various studies, highlighting its promise in treating CKD; however, supporting evidence remains limited, making it crucial to conduct further investigations to determine the specific effects of different probiotic formulations on outcomes in patients with CKD.

Research Insights

Lactobacillus acidophilus L-92→Improved Gastrointestinal Symptoms
Probiotics and prebiotics have recently garnered attention owing to their potential to enhance gastrointestinal health and well-being by restoring the balance of the gut microbiota.
Effect
Beneficial
Effect size
Small
Lactobacillus acidophilus L-92→Improved Gut Microbiota Balance
Specific probiotic strains, including Lactobacillus and Bifidobacterium, promote beneficial bacterial growth, suppress harmful bacteria, and exert anti-inflammatory, antihypertensive, and antidiabetic effects.
Effect
Beneficial
Effect size
Small
Lactobacillus acidophilus L-92→Improved Immune-Related Symptoms
Lactobacillus acidophilus L-92 has been reported to improve various allergic symptoms and modulate immune responses.
Effect
Beneficial
Effect size
Moderate
Lactobacillus acidophilus L-92→Reduced Blood Glucose Levels
Specific probiotic strains, including Lactobacillus and Bifidobacterium, promote beneficial bacterial growth, suppress harmful bacteria, and exert anti-inflammatory, antihypertensive, and antidiabetic effects.
Effect
Beneficial
Effect size
Small
Lactobacillus acidophilus L-92→Reduced Blood Pressure
Specific probiotic strains, including Lactobacillus and Bifidobacterium, promote beneficial bacterial growth, suppress harmful bacteria, and exert anti-inflammatory, antihypertensive, and antidiabetic effects.
Effect
Beneficial
Effect size
Small
Lactobacillus acidophilus L-92→Reduced Inflammation
Specific probiotic strains, including Lactobacillus and Bifidobacterium, promote beneficial bacterial growth, suppress harmful bacteria, and exert anti-inflammatory, antihypertensive, and antidiabetic effects.
Effect
Beneficial
Effect size
Small